Acrotech Biopharma Inc.

This study is testing whether adding one of two newer drugs (belinostat or pralatrexate) to standard chemotherapy works better than standard chemotherapy alone for people newly diagnosed with peripheral T-cell lymphoma, a rare and aggressive blood cancer. The goal is to see if th…

This early-stage study aims to understand how the cancer drug pralatrexate is processed by the body in people with varying degrees of liver impairment. It will involve about 24 adults with advanced solid tumors or blood cancers. The main goal is to measure drug levels in the bloo…